Replies to post #217881 on Biotech Values

[DewDiligence]

Shocking, but true:

#ASCCP2018
Kimberly Gecsi: One third of the women in our survey of ~60 women (average age in their 30s) did not associate the HPV vaccine with cervical cancer prevention. Most stated their health care provider never discussed the vaccine.

— Elisabeth Bik (@MicrobiomDigest) April 20, 2018

[DewDiligence]

FDA approves Ketruda monotherapy in second-line cervical cancer for patients with PD-L1 expression ≥1%:

https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm610572.htm

This is an accelerated approval based on the single-arm KEYNOTE-158 study. (The PDUFA date was6/28/18.)